Latigo Biotherapeutics Statistics
Total Valuation
LTGO has a market cap or net worth of $835.37 million. The enterprise value is $435.15 million.
| Market Cap | 835.37M |
| Enterprise Value | 435.15M |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LTGO has 66.30 million shares outstanding. The number of shares has increased by 1,126.55% in one year.
| Current Share Class | 66.30M |
| Shares Outstanding | 66.30M |
| Shares Change (YoY) | +1,126.55% |
| Shares Change (QoQ) | +3,946.74% |
| Owned by Insiders (%) | 6.52% |
| Owned by Institutions (%) | 8.30% |
| Float | 21.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.21 |
| P/TBV Ratio | 2.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 28.13, with a Debt / Equity ratio of 0.00.
| Current Ratio | 28.13 |
| Quick Ratio | 27.78 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -116.41 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -28.07% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.63M |
| Employee Count | 66 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 17.95 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 35.13 |
| Average Volume (20 Days) | 228,469 |
Short Selling Information
The latest short interest is 785,880, so 1.19% of the outstanding shares have been sold short.
| Short Interest | 785,880 |
| Short Previous Month | 832,088 |
| Short % of Shares Out | 1.19% |
| Short % of Float | 3.61% |
| Short Ratio (days to cover) | 1.91 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -110.59M |
| Pretax Income | -107.29M |
| Net Income | -107.29M |
| EBITDA | -110.38M |
| EBIT | -110.59M |
| Earnings Per Share (EPS) | -$10.42 |
Balance Sheet
The company has $401.41 million in cash and $1.19 million in debt, with a net cash position of $400.22 million or $6.04 per share.
| Cash & Cash Equivalents | 401.41M |
| Total Debt | 1.19M |
| Net Cash | 400.22M |
| Net Cash Per Share | $6.04 |
| Equity (Book Value) | 393.97M |
| Book Value Per Share | 10.41 |
| Working Capital | 392.00M |
Cash Flow
In the last 12 months, operating cash flow was -$103.19 million and capital expenditures -$111,000, giving a free cash flow of -$103.30 million.
| Operating Cash Flow | -103.19M |
| Capital Expenditures | -111,000 |
| Depreciation & Amortization | 207,000 |
| Net Borrowing | 35.00M |
| Free Cash Flow | -103.30M |
| FCF Per Share | -$1.56 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LTGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1,126.55% |
| Shareholder Yield | -1,126.55% |
| Earnings Yield | -82.70% |
| FCF Yield | -12.37% |
Analyst Forecast
The average price target for LTGO is $52.25, which is 314.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $52.25 |
| Price Target Difference | 314.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |